Keywords: xenova, begins, xr9576, phase, ii, trials, plans

Xenova Begins XR9576 Phase II Trials

Article | 17 December 1998

Print This

Xenova has plans to begin Phase II trials of its low molecular weightP-glycoprotein pump inhibitor, XR9576, in the first quarter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in